Cardiovascular Systems Revenue, Growth & Competitor Profile

DBA CSI

Company Profile & Annual Report for Cardiovascular Systems

Access the complete profile.

Cardiovascular Systems Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	1225 Old Highway 8 Nw Saint Paul, MN 55112

Note: Revenues for privately held companies are statistical evaluations.


Cardiovascular Systems's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cardiovascular Systems's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Cardiovascular Systems is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Cardiovascular Systems Annual Revenue and Growth Rate

Cardiovascular Systems	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cardiovascular Systems's revenues are gauged from an analysis of company filings.

Cardiovascular Systems's Income Statement (based on Industry Averages)

Cardiovascular Systems P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Cardiovascular Systems is developing and marketing. Cardiovascular Systems doesn't have any recent trademark applications, indicating Cardiovascular Systems is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FURY Medical devices for use in treating or diagnosing vascular disease	04/22/2023
SIREN Medical devices for use in treating or diagnosing vascular disease	04/22/2023
ALECTO Medical devices for use in treating or diagnosing vascular disease	02/16/2023

See all trademarks and details in the Full Report.

Market Share of Cardiovascular Systems's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cardiovascular Systems, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Cardiovascular Systems. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MFG SOLUTIONS INC DBA NEXTERN IN	White Bear Lake, MN	100
CARDIOVASCULAR SYSTEMS	Saint Paul, MN	97
MEDICAL GRAPHICS	Vadnais Heights, MN	20
SUMMIT MEDICAL	Eagan, MN	19
MODERN CATHETER TECHNOLOGIES	Maplewood, MN	19
MGC DIAGNOSTICS HOLDINGS	Saint Paul, MN	16

Future Competition: Cardiovascular Systems's Fastest Growing Competitors

These companies are in the same general field as Cardiovascular Systems and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)